PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
03-May-2023 ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Results Show Statistically Significant Improvements in PFS, ORR, and OS Compared to Chemotherapy First Medicine to Demonstrate an Overall Survival Advantage in Platinum-Resistant Ovarian Cancer Submission of MAA in Europe and sBLA in US Anticipated in H2 2023 ImmunoGen Inc.
02-May-2023 Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology OptraSCAN Inc
27-Apr-2023 ISA Pharmaceuticals to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting ISA Pharmaceuticals
26-Apr-2023 AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy AMO Pharma
25-Apr-2023 Greenphire Launches GreenSpace App and Expands Global Payment Functionality Greenphire
21-Apr-2023 B Corp Recruitment firm RBW Consulting launches findings from its second IMPACT initiative RBW Consulting
20-Apr-2023 Evaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints Evaxion
19-Apr-2023 Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality Veeva Systems
19-Apr-2023 Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck Oxford BioTherapeutics
18-Apr-2023 Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023 Avance Clinical
13-Apr-2023 atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) atai Life Sciences
12-Apr-2023 Almirall, the first to assess wellbeing in a dermatology clinical study Almirall
11-Apr-2023 Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Phastar
11-Apr-2023 Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up Paradigm Biopharmaceuticals
11-Apr-2023 TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50% TrialWire
10-Apr-2023 CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis CD Bioparticles
10-Apr-2023 CD BioSciences Launches Fluorescence Correlation Spectroscopy CD BioSciences
10-Apr-2023 CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death CD BioSciences
10-Apr-2023 Creative Diagnostics Introduces Virus Yield Reduction Assay Service Creative Diagnostics
10-Apr-2023 Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers Creative Diagnostics